ResMed Inc.RMDNYSE

|||

Overview News Chart Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Latest News

globenewswire.com

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.

zacks.com

Here's Why ResMed (RMD) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com

Is This the Right Time to Add Resmed Stock to Your Portfolio?

RMD is seeing rising device demand, expanding international sales and strong liquidity, but macroeconomic pressures could weigh on future performance.

defenseworld.net

ResMed (NYSE:RMD) General Counsel Michael Rider Sells 50 Shares

ResMed Inc. (NYSE: RMD - Get Free Report) General Counsel Michael Rider sold 50 shares of the stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $241.75, for a total transaction of $12,087.50. Following the sale, the general counsel directly owned 9,741 shares of the company's

defenseworld.net

ResMed Inc. $RMD Shares Sold by Chicago Capital LLC

Chicago Capital LLC cut its holdings in ResMed Inc. (NYSE: RMD) by 14.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 15,481 shares of the medical equipment provider's stock after selling 2,541 shares during the quarter. Chicago Capital LLC's holdings

defenseworld.net

Railway Pension Investments Ltd Increases Position in ResMed Inc. $RMD

Railway Pension Investments Ltd increased its position in shares of ResMed Inc. (NYSE: RMD) by 299.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 9,605 shares of the medical equipment provider's stock after acquiring an additional 7,200 shares during the

zacks.com

Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes"

ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

zacks.com

Buy These 5 Low-Leverage Stocks Amid a Reversal of Santa Claus Rally

A stalled Santa Claus rally has investors rotating to stability, spotlighting low-leverage names like Resmed that may hold up better amid tech-led volatility.

zacks.com

BSX vs. RMD: Which Medical Device Stock Is the Stronger Play Now?

Boston Scientific edges out Resmed as WATCHMAN momentum, EP gains and acquisitions fuel stronger recent price performance in a growing medical device market.

zacks.com

3 Stocks Likely to Gain From Rising HSA Contribution & Medicare Premium

Rising HSA limits and higher Medicare premiums in 2026 could lift demand for chronic care devices from DexCom, ResMed and Masimo.

defenseworld.net

Perigon Wealth Management LLC Grows Holdings in ResMed Inc. $RMD

Perigon Wealth Management LLC increased its stake in shares of ResMed Inc. (NYSE: RMD) by 9.4% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 24,482 shares of the medical equipment provider's stock after purchasing an additional 2,110 shares during the period. Perigon Wealth Management

zacks.com

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

defenseworld.net

ResMed Inc. $RMD Shares Acquired by Addenda Capital Inc.

Addenda Capital Inc. grew its holdings in ResMed Inc. (NYSE: RMD) by 41.6% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 77,456 shares of the medical equipment provider's stock after buying an additional 22,741 shares during the period. Addenda Capital Inc. owned 0.05% of ResMed

globenewswire.com

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, beginning at approximately 10:30 a.m. (Pacific Standard Time) in San Francisco, CA.

defenseworld.net

First Trust Advisors LP Acquires 3,390 Shares of ResMed Inc. $RMD

First Trust Advisors LP raised its holdings in shares of ResMed Inc. (NYSE: RMD) by 3.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 115,610 shares of the medical equipment provider's stock after purchasing an additional 3,390 shares during the

zacks.com

RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort

Resmed gains FDA's nod for Smart Comfort, an AI-driven CPAP tool boosting sleep therapy personalization and adherence.

seekingalpha.com

Top 50 High-Quality Dividend Growth Stocks For December 2025

I track a custom universe of 50 high-quality dividend growth stocks to identify timely, attractive investment opportunities based on valuation and forward return potential. 28 of these stocks currently offer estimated future returns of at least 10%, with 18 appearing potentially undervalued per my Free Cash Flow model. Top-ranked names like ResMed, Mastercard, and MSCI combine strong projected EPS growth with reasonable valuations.

globenewswire.com

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Settings (PTCS), to be marketed as Smart Comfort. Smart Comfort is the first FDA-cleared AI-enabled medical device that recommends personalized comfort settings to help people with obstructive sleep apnea (OSA) start and stay on CPAP therapy.

zacks.com

Should You Continue to Hold RMD Stock in Your Portfolio?

Resmed sees strong mask sales, strategic acquisitions and international expansion despite macro and competitive challenges.

defenseworld.net

ResMed Inc. $RMD Shares Sold by Elevation Point Wealth Partners LLC

Elevation Point Wealth Partners LLC lowered its position in ResMed Inc. (NYSE: RMD) by 91.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 243 shares of the medical equipment provider's stock after selling 2,629 shares during the period. Elevation Point Wealth Partners

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance